RAD52 and hepatocellular carcinoma: In particular, a direct correlation between specific RAD52 single-nucleotide polymorphisms (SNP) and tumorigenic risk was speculated, for instance in hepatitis B virus (HBV)—hepatocellular carcinoma (HCC) [85] and in colorectal cancer [86].